30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Heartflow Inc (HTFL)

Track

Over the last 90 days, Heartflow Inc. has seen significant insider selling, with a net value of -$58.9 million. This activity is primarily driven by large sell transactions from Bain Capital Life Sciences Investors, LLC. Executive sales are also noted, including planned and proposed sales by CEO John C.M. Farquhar and Officer Campbell Rogers.
Stock chart
Ticker: HTFL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Farquhar John C.M.
Chief Executive Officer
2 sales — total 200,000 USD
Planned sale 10 Jun 2026
Value US$1,818,550.46 | Price 214.42 | Shares 66,930
Proposed sale 10 Jun 2026
Value US$694,470.87 | Price 191.80 | Shares 3,457
Planned sale 18 May 2026
Value US$2,731,055.05 | Price 409.46 | Shares 1,886
Proposed sale 18 May 2026
Value US$4,245,528.23 | Price 229.63 | Shares 65,180
Planned sale 11 May 2026
Value US$657,005.44 | Price 29.12 | Shares 22,562
Proposed sale 11 May 2026
Value US$657,005.44 | Price 29.12 | Shares 22,562
Sale 30 Apr 2026
Value US$1,689,531.20 | Price 30.05 | Shares 56,224
Sale 30 Apr 2026
Value US$26,044,112.94 | Price 29.18 | Shares 892,533
Sale 29 Apr 2026
Value US$23,411,796.21 | Price 29.37 | Shares 797,133
Sale 28 Apr 2026
Value US$7,752,896.10 | Price 30.51 | Shares 254,110
Planned sale 10 Apr 2026
Value US$602,856.64 | Price 26.72 | Shares 22,562
Proposed sale 10 Apr 2026
Value US$602,856.64 | Price 26.72 | Shares 22,562
Planned sale 1 Apr 2026
Value US$1,590,093.12 | Price 24.64 | Shares 64,533
Proposed sale 1 Apr 2026
Value US$1,589,934.72 | Price 24.64 | Shares 64,533
Planned sale 19 Mar 2026
Value US$1,658,033.46 | Price 25.69 | Shares 64,533
Proposed sale 19 Mar 2026
Value US$1,658,030.49 | Price 25.69 | Shares 64,533
Planned sale 18 Mar 2026
Value US$243,125.00 | Price 25.00 | Shares 9,725
Proposed sale 18 Mar 2026
Value US$243,125.00 | Price 25.00 | Shares 9,725
Planned sale 10 Mar 2026
Value US$290,886.42 | Price 22.66 | Shares 12,837
Proposed sale 10 Mar 2026
Value US$290,886.42 | Price 22.66 | Shares 12,837
Planned sale 5 Mar 2026
Value US$228,050.00 | Price 25.00 | Shares 9,122
Proposed sale 5 Mar 2026
Value US$228,050.00 | Price 25.00 | Shares 9,122
Planned sale 12 Feb 2026
Value US$1,595,486.21 | Price 24.49 | Shares 65,153
Proposed sale 12 Feb 2026
Value US$1,595,485.25 | Price 24.49 | Shares 65,153
Planned sale 10 Feb 2026
Value US$619,552.52 | Price 27.46 | Shares 22,562
Proposed sale 10 Feb 2026
Value US$619,556.99 | Price 27.46 | Shares 22,562
Proposed sale 5 Feb 2026
Value US$218,560.00 | Price 27.32 | Shares 8,000
Planned sale 5 Feb 2026
Value US$218,560.00 | Price 27.32 | Shares 8,000
Proposed sale 5 Feb 2026
Value US$218,560.00 | Price 27.32 | Shares 8,000
Sale 4 Feb 2026
Value US$56,100,000.00 | Price 28.05 | Shares 2,000,000
Buy 16 Dec 2025
Value US$1,053,680.00 | Price 26.34 | Shares 40,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
66,930 -21.4%
214.42
US$1,818,550 		66,930 -21.4% 214.42 US$1,818,550
2026-06-10 2026-06-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
3,457
191.80
US$694,471 		3,457 191.80 US$694,471
2026-05-20 2026-05-18 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
1,886 -3.4%
409.46
US$2,731,055 		1,886 -3.4% 409.46 US$2,731,055
2026-05-18 2026-05-18 PrS Proposed sale
Rogers Campbell

Officer

Officer
9,219
28.34
US$261,266 		9,219 28.34 US$261,266
2026-05-13 2026-05-11 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -4.2%
29.12
US$657,005 		22,562 -4.2% 29.12 US$657,005
2026-05-11 2026-05-11 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
29.12
US$657,005 		22,562 29.12 US$657,005
2026-04-30 2026-04-30 S Sale
2.7
Bain Capital Life Sciences Investors, LLC
Large shareholder
56,224 -0.7%
30.05
US$1,689,531 		56,224 -0.7% 30.05 US$1,689,531
2026-04-30 2026-04-30 S Sale
2.7
Bain Capital Life Sciences Investors, LLC
Large shareholder
892,533 -9.5%
29.18
US$26,044,113 		892,533 -9.5% 29.18 US$26,044,113
2026-04-30 2026-04-29 S Sale
2.7
Bain Capital Life Sciences Investors, LLC
Large shareholder
797,133 -7.8%
29.37
US$23,411,796 		797,133 -7.8% 29.37 US$23,411,796
2026-04-30 2026-04-28 S Sale
2.7
Bain Capital Life Sciences Investors, LLC
Large shareholder
254,110 -2.4%
30.51
US$7,752,896 		254,110 -2.4% 30.51 US$7,752,896
2026-04-14 2026-04-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -3.9%
26.72
US$602,857 		22,562 -3.9% 26.72 US$602,857
2026-04-10 2026-04-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
26.72
US$602,857 		22,562 26.72 US$602,857
2026-04-03 2026-04-01 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
64,533 -44.3%
24.64
US$1,590,093 		64,533 -44.3% 24.64 US$1,590,093
2026-04-01 2026-04-01 PrS Proposed sale
Rogers Campbell

Officer

Officer
64,533
24.64
US$1,589,935 		64,533 24.64 US$1,589,935
2026-03-23 2026-03-19 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
64,533 -45.1%
25.69
US$1,658,033 		64,533 -45.1% 25.69 US$1,658,033
2026-03-19 2026-03-19 PrS Proposed sale
Rogers Campbell

Officer

Officer
64,533
25.69
US$1,658,030 		64,533 25.69 US$1,658,030
2026-03-20 2026-03-18 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
9,725 -1.7%
25.00
US$243,125 		9,725 -1.7% 25.00 US$243,125
2026-03-18 2026-03-18 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
9,725
25.00
US$243,125 		9,725 25.00 US$243,125
2026-03-12 2026-03-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
12,837 -2.2%
22.66
US$290,886 		12,837 -2.2% 22.66 US$290,886
2026-03-10 2026-03-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
12,837
22.66
US$290,886 		12,837 22.66 US$290,886
2026-03-06 2026-03-05 PlS Planned sale
3.2
Cullivan Julie A
Non-Executive Director
9,122 -25.1%
25.00
US$228,050 		9,122 -25.1% 25.00 US$228,050
2026-03-05 2026-03-05 PrS Proposed sale
3.2
Cullivan Julie A

Director

Non-Executive Director
9,122
25.00
US$228,050 		9,122 25.00 US$228,050
2026-02-17 2026-02-12 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
65,153 -46.1%
24.49
US$1,595,486 		65,153 -46.1% 24.49 US$1,595,486
2026-02-12 2026-02-12 PrS Proposed sale
Rogers Campbell

Officer

Officer
65,153
24.49
US$1,595,485 		65,153 24.49 US$1,595,485
2026-02-10 2026-02-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -3.7%
27.46
US$619,553 		22,562 -3.7% 27.46 US$619,553
2026-02-10 2026-02-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
27.46
US$619,557 		22,562 27.46 US$619,557
2026-02-12 2026-02-05 PrS Proposed sale
3.2
Cullivan Julie A

Director

Non-Executive Director
8,000
27.32
US$218,560 		8,000 27.32 US$218,560
2026-02-06 2026-02-05 PlS Planned sale
3.2
Cullivan Julie A
Non-Executive Director
8,000 -18.0%
27.32
US$218,560 		8,000 -18.0% 27.32 US$218,560
2026-02-05 2026-02-05 PrS Proposed sale
3.2
Cullivan Julie A

Director

Non-Executive Director
8,000
27.32
US$218,560 		8,000 27.32 US$218,560
2026-02-06 2026-02-04 S Sale
2.7
Bain Capital Life Sciences Investors, LLC
Large shareholder
2,000,000 -16.1%
28.05
US$56,100,000 		2,000,000 -16.1% 28.05 US$56,100,000
2025-12-17 2025-12-16 B Purchase
2.3
Lightcap Jeffrey C
Non-Executive Director
40,000 +inf%
26.34
US$1,053,680 		40,000 +inf% 26.34 US$1,053,680
Explore more

More insider trading research around Heartflow Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America